Patents by Inventor Gregory S. May

Gregory S. May has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and systems for authorizing call forwarding
    Patent number: 8867726
    Abstract: A call forwarding server in a telephony network is configured to provide an authorization function during activation of a call forwarding service. In response to receiving a forwarding request including initiating and terminating telephone numbers (TN), the call forwarding server generates and sends a request for the terminating TN to obtain authorization for the forwarding service. In response to receiving an authorization response for enabling call forwarding, the call forwarding server enables call forwarding for the initiating TN by updating a call forwarding record to include an entry including the initiating TN and the terminating TN. Communications placed to the initiating TN are automatically forwarded to the terminating TN once the forwarding service is enabled.
    Type: Grant
    Filed: June 6, 2012
    Date of Patent: October 21, 2014
    Assignee: Cellco Partnership
    Inventors: Carlos A. Cazanas, Azam Khan, Robin P. Clair, Gregory S. May
  • METHODS AND SYSTEMS FOR AUTHORIZING CALL FORWARDING
    Publication number: 20130329878
    Abstract: A call forwarding server in a telephony network is configured to provide an authorization function during activation of a call forwarding service. In response to receiving a forwarding request including initiating and terminating telephone numbers (TN), the call forwarding server generates and sends a request for the terminating TN to obtain authorization for the forwarding service. In response to receiving an authorization response for enabling call forwarding, the call forwarding server enables call forwarding for the initiating TN by updating a call forwarding record to include an entry including the initiating TN and the terminating TN. Communications placed to the initiating TN are automatically forwarded to the terminating TN once the forwarding service is enabled.
    Type: Application
    Filed: June 6, 2012
    Publication date: December 12, 2013
    Applicant: Cellco Partnership d/b/a Verizon Wireless
    Inventors: Carlos A. Cazanas, Azam Khan, Robin P. Clair, Gregory S. May
  • Production of recombinant lactoferrin and lactoferrin polypeptides using cDNA sequences in various organisms
    Patent number: 6635447
    Abstract: The verified cDNA sequences for human, bovine and porcine lactoferrin protein have been used to prepare recombinant lactoferrin for therapeutic and nutritional applications. Regions of the cDNA such as the Fe binding sites can be used to make an hLF polypeptide product. The present invention provides novel plasmids, transfected eucaryotic cells and methods of producing these plasmids and transfected eucaryotic cells. The novel plasmid contains the cDNA for lactoferrin protein. Methods for the production of lactoferrin protein in fungi and bacteria are also provided. Thus, the present invention provides an efficient and economical means for the production of recombinant lactoferrin protein and lactoferrin related polypeptides.
    Type: Grant
    Filed: August 7, 2000
    Date of Patent: October 21, 2003
    Assignee: Baylor College of Medicine
    Inventors: Orla M. Conneely, Denis R. Headon, Bert W. O'Malley, Gregory S. May
  • Production of recombinant lactoferrin and lactoferrin polypeptides using cDNA sequences in various organisms
    Patent number: 6228614
    Abstract: The verified cDNA sequences for human, bovine and porcine lactoferrin protein have been used to prepare recombinant lactoferrin for therapeutic and nutritional applications. Regions of the cDNA such as the Fe binding sites can be used to make an hLF polypeptide product. The present invention provides novel plasmids, transfected eucaryotic cells and methods of producing these plasmids and transfected eucaryotic cells. The novel plasmid contains the cDNA for lactoferrin protein. Methods for the production of lactoferrin protein in fungi and bacteria are also provided. Thus, the present invention provides an efficient and economical means for the production of recombinant lactoferrin protein and lactoferrin related polypeptides.
    Type: Grant
    Filed: March 9, 1999
    Date of Patent: May 8, 2001
    Assignee: Baylor College of Medicine
    Inventors: Orla M. Conneely, Denis R. Headon, Bert W. O'Malley, Gregory S. May
  • Production for recombinant lactoferrin and lactoferrin polypeptides using DNA sequences in various organisms
    Patent number: 6100054
    Abstract: The verified cDNA sequences for human, bovine and porcine lactoferrin protein have been used to prepare recombinant lactoferrin for therapeutic and nutritional applications. Regions of the cDNA such as the Fe binding sites can be used to make an hLF polypeptide product.The present invention provides novel plasmids, transfected eucaryotic cells and methods of producing these plasmids and transfected eucaryotic cells. The novel plasmid contains the cDNA for lactoferrin protein. Methods for the production of lactoferrin protein in fungi and bacteria are also provided. Thus, the present invention provides an efficient and economical means for the production of recombinant lactoferrin protein and lactoferrin related polypeptides.
    Type: Grant
    Filed: May 30, 1995
    Date of Patent: August 8, 2000
    Assignee: Baylor College of Medicine
    Inventors: Orla M. Conneely, Denis R. Headon, Bert W. O'Malley, Gregory S. May
  • Production of recombinant lactoferrin and lactoferrin polypeptides using cDNA sequences in various organisms
    Patent number: 5849881
    Abstract: The verified cDNA sequences for human, bovine and porcine lactoferrin protein have been used to prepare recombinant lactoferrin for therapeutic and nutritional applications. Regions of the cDNA such as the Fe binding sites can be used to make an hLF polypeptide product.The present invention provides novel plasmids, transfected eucaryotic cells and methods of producing these plasmids and transfected eucaryotic cells. The novel plasmid contains the cDNA for lactoferrin protein. Methods for the production of lactoferrin protein in fungi and bacteria are also provided. Thus, the present invention provides an efficient and economical means for the production of recombinant lactoferrin protein and lactoferrin related polypeptides.
    Type: Grant
    Filed: May 30, 1995
    Date of Patent: December 15, 1998
    Inventors: Orla M. Conneely, Denis R. Headon, Bert W. O'Malley, Gregory S. May
  • Production of recombinant lactoferrin and lactoferrin polypeptides using CDNA sequences in various organisms
    Patent number: 5766939
    Abstract: The verified cDNA sequences for human, bovine and porcine lactoferrin protein have been used to prepare recombinant lactoferrin for therapeutic and nutritional applications. Regions of the cDNA such as the Fe binding sites can be used to make an hLF polypeptide product.The present invention provides novel plasmids, transfected eucaryotic cells and methods of producing these plasmids and transfected eucaryotic cells. The novel plasmid contains the cDNA for lactoferrin protein. Methods for the production of lactoferrin protein in fungi and bacteria are also provided. Thus, the present invention provides an efficient and economical means for the production of recombinant lactoferrin protein and lactoferrin related polypeptides.
    Type: Grant
    Filed: May 30, 1995
    Date of Patent: June 16, 1998
    Assignee: Baylor College of Medicine
    Inventors: Orla M. Conneely, Denis R. Headon, Bert W. O'Malley, Gregory S. May
  • Production of recombinant human lactoferrin
    Patent number: 5571896
    Abstract: The present invention provides novel plasmids, transfected eucaryotic cells and methods of producing these plasmids and transfected eucaryotic cells. The novel plasmid contains the cDNA for human lactoferrin protein. Methods for the production of human lactoferrin protein in A. Oryzae are also provided. Thus, the present invention provides an efficient and economical means for the production of recombinant human lactoferrin protein.
    Type: Grant
    Filed: May 27, 1994
    Date of Patent: November 5, 1996
    Assignee: Baylor College of Medicine
    Inventors: Orla M. Conneely, Denis R. Headon, Bert W. O'Malley, Gregory S. May
  • Production of recombinant lactoferrin and lactoferrin polypeptides using CDNA sequences in various organisms
    Patent number: 5571691
    Abstract: The verified cDNA sequences for human, bovine and porcine lactoferrin protein have been used to prepare recombinant lactoferrin for therapeutic and nutritional applications. Regions of the cDNA such as the Fe binding sites can be used to make an hLF polypeptide product.The present invention provides novel plasmids, transfected eucaryotic cells and methods of producing these plasmids and transfected eucaryotic cells. The novel plasmid contains the cDNA for lactoferrin protein. Methods for the production of lactoferrin protein in fungi and bacteria are also provided. Thus, the present invention provides an efficient and economical means for the production of recombinant lactoferrin protein and lactoferrin related polypeptides.
    Type: Grant
    Filed: October 28, 1993
    Date of Patent: November 5, 1996
    Assignee: Baylor College of Medicine
    Inventors: Orla M. Conneely, Denis R. Headon, Bert W. O'Malley, Gregory S. May